News Clip0:23
Curated Video

California Mandates COVID-19 Booster Shots For Health Care Workers

Higher Ed
Gov. Gavin Newsom announced the order Tuesday from his personal Twitter account.
News Clip4:42
Bloomberg

Have To Consider Nuances In Space Investing: Hatch

Higher Ed
Jun.11 -- Tess Hatch, Partner at Bessemer Venture Partners, says that investors have to consider the nuances of investing in space-related companies that distinguish them from investing in software. She joins David Westin on "Bloomberg...
News Clip3:03
Bloomberg

AstraZeneca Begins U.S. Final-Stage Covid-19 Vaccine Trial

Higher Ed
Sep.01 -- AstraZeneca Plc has begun testing its coronavirus vaccine in a large-scale human trial that could include up to 30,000 adults. Bloomberg Intelligence’s Sam Fazeli has the details on “Bloomberg Surveillance.”
News Clip2:21
Bloomberg

Vaccines May Not Prevent Covid From Becoming Endemic: Heymann

Higher Ed
Sep.29 -- London School of Hygiene & Tropical Medicine Professor David Heymann examines expectations for a coronavirus vaccine and concerns about protecting the world’s older population. He speaks on "Bloomberg Markets: European Close."
News Clip8:35
Bloomberg

Novavax Vaccine Will Probably Work on New Covid Strain: CEO

Higher Ed
Dec.28 -- Novavax Inc. Chief Executive Officer Stan Erck discusses the phase 3 trial of the company's Covid-19 vaccine and says the data so far have been at or above the levels of Moderna Inc. and Pfizer Inc. He speaks with Bloomberg's...
News Clip12:17
Bloomberg

Pandemic Has Proven Robustness of Cloud Technology: TCS COO

Higher Ed
Jan.18 -- N. Ganapathy Subramaniam, chief operating officer at Tata Consultancy Services Ltd., discusses how the company was impacted by the coronavirus pandemic, productivity from work-from-home employees and the technologies he sees...
News Clip0:29
Curated Video

FDA Endorses Moderna Vaccine Candidate For Emergency Use

Higher Ed
An FDA advisory committee is set to meet Thursday to consider approving the vaccine candidate for emergency use.
News Clip8:34
Bloomberg

T. Rowe Price's Poullaouec on Archegos Capital, How His Firm is Mitigating Risk

Higher Ed
Mar.31 -- Thomas Poullaouec, T. Rowe Price Head of APAC Multi-Asset Solutions, discusses the Archegos Capital fallout, how his firm is mitigating risk, and how the Chinese market is heavily skewed towards the tech sector. He speaks with...
News Clip4:33
Bloomberg

Positive on Risk Assets in Medium Term, BlackRock's Seth Says

Higher Ed
Nov.11 -- BlackRock MD & Head of Asian Credit Neeraj Seth says he is positive on risk assets in the medium term. He was speaking with Juliette Saly and Rishaad Salamat on "Bloomberg Markets: Asia."
News Clip2:53
Bloomberg

Covid-19 Antibody Treatments Need More Work: Johns Hopkins

Higher Ed
Jul.22 -- Johns Hopkins Assistant Professor of Emergency Medicine Lauren Sauer discusses understanding how antibody production works in the fight against Covid-19. She speaks with Bloomberg’s Francine Lacqua on "Bloomberg Surveillance."...
News Clip3:38
Bloomberg

Chinas Dengue Fight Sees Hope in Sanofi Vaccine

Higher Ed
Oct. 8 -- Bloomberg Intelligences Sam Fazeli discusses Chinas fight to contain an outbreak of Dengue fever, as six people have succumbed to the virus and efforts by Sanofi to develop a Dengue vaccine. He speaks on The Pulse.
News Clip3:25
Curated Video

Scientists make progress in search for vaccine

Higher Ed
1. Pan exterior of Robert Koch Institute 2. Medium shot Robert Koch Institute 3. Reinhard Kurt, Frans van den Boom and Jan van Lunzen entering 4. Auditorium 5. SOUNDBITE (German) Jan van Lunzen, University Hospital of Hamburg...
News Clip1:11
Curated Video

EU Gets Its First Vaccine Shipments, Hungary Administers First Doses

Higher Ed
Hungary has started administering the vaccine, the first in a coordinated rollout for 27 European Union countries.
News Clip2:20
The Recount

Ivermectin is Not a COVID ‘Wonder Drug’

Higher Ed
Poison control calls have jumped 880% for the “horse dewormer” drug ivermectin. Yes, it’s FDA-approved for humans—to treat parasitic worms. No, it’s not effective against COVID, according to the latest clinical trial data.
News Clip5:40
The Recount

Gruden Gone: Raiders Coach Resigns Over Offensive Emails

Higher Ed
Seems like Jon Gruden’s racism, misogyny, and homophobia finally caught up to him. Texas Gov. Greg Abbott says one thing and does another. Plus, what’s up with Southwest Airline delays?
News Clip2:00
Bloomberg

Biden Says It's Time to Get Back to Work and School

Higher Ed
President Joe Biden says with Covid-19 cases down, it's time to get back to work and school. He spoke during the State of the Union address.
News Clip0:26
Curated Video

U.S. Clears Updated COVID Boosters For Kids As Young As 5 Years Old

Higher Ed
The boosters, rolled out for Americans 12 and older last month, are doses modified to target today's most common and contagious Omicron relatives.
News Clip3:17
Sky News

UK: Pfizer vaccine success a 'real boost' but don't expect a jab in the next few weeks, says top scientist

Higher Ed
VOICED: The Prime Minister stressed today that these are 'very, very early days' in the race for a vaccine. But it is hard to see today's announcement as anything other than good news. Our home editor Jason Farrell has been...
News Clip1:17
Curated Video

Samoa To Shut Down Government To Help With Measles Outbreak

Higher Ed
More than 3,700 cases of measles have been reported in Samoa, according to government data released Monday.
News Clip6:40
Bloomberg

Reopening Trade Delayed, But Not Derailed: Barton

Higher Ed
Apr.23 -- Eaton Vance Equity Portfolio Manager Yana Barton says that the uneven economic recovery and vaccine distribution has delayed the reopening trade. She joins David Westin on "Bloomberg Wall Street Week."
News Clip4:49
Press Association

PM: Government fighting to secure release of Nazanin Zaghari-Ratcliffe

Higher Ed
Prime Minister Boris Johnson answers questions at Next World Sports during a visit to the company, in Wrexham. He said that the Government will be “working very hard” to secure the release of Nazanin Zaghari-Ratcliffe, telling reporters:...
News Clip2:47
Bloomberg

AstraZeneca Vaccine Deemed ‘Safe and Effective’ by EMA

Higher Ed
Mar.18 -- The European Medicines Agency said AstraZeneca Plc’s Covid-19 vaccine is safe to use after several European nations suspended use of the shots over concerns about blood clots. EMA Executive Director Emer Cooke speaks at a press...
News Clip2:51
Bloomberg

The Digital Apps That Store Proof of Vaccination

Higher Ed
Aug.18 -- Common Project CEO Paul Meyer speaks to Emily Chang about the field of vaccine verification apps and how they integrate with Google, Apple, and Samsung phones, a critical step forward as businesses and offices start to demand...
News Clip5:04
Bloomberg

Cirque du Soleil Survival After Bankruptcy Is Guaranteed, CEO Says

Higher Ed
Jun.30 -- Cirque du Soleil Entertainment Group Chief Executive Officer Daniel Lamarre discusses the future for the 36-year-old company after filing for protection from creditors in Canada on Monday. He speaks on "What'd You Miss?"